Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Aurelien Dupré"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, Thomas Boerner, Yu Ma, Jane Wang, Carsten Kamphues, Kazunari Sasaki, Seehanah Tang, Johan Gagniere, Aurelien Dupré, Inger Marie Løes, Doris Wagner, Georgios Stasinos, Andrea Macher-Beer, Richard Burkhart, Daisuke Morioka, Katsunori Imai, Victoria Ardiles, Juan Manuel O’Connor, Timothy M. Pawlik, George Poultsides, Hendrik Seeliger, Katharina Beyer, Klaus Kaczirek, Peter Kornprat, Federico N. Aucejo, Eduardo de Santibañes, Hideo Baba, Itaru Endo, Per Eystein Lønning, Martin E. Kreis, Matthew J. Weiss, Christopher L. Wolfgang, Michael D’Angelica
Publikováno v:
JAMA Surg
IMPORTANCE: In patients with resectable colorectal cancer liver metastases (CRLM), the choice of surgical technique and resection margin are the only variables that are under the surgeon’s direct control and may influence oncologic outcomes. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0215ab500bf7ca7a41cf74e0724f759
https://europepmc.org/articles/PMC9161118/
https://europepmc.org/articles/PMC9161118/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sahir Javed, Stéphane Benoist, Patrick Devos, Stéphanie Truant, Rosine Guimbaud, Astrid Lièvre, David Sefrioui, Romain Cohen, Pascal Artru, Aurélien Dupré, Jean-Baptiste Bachet, Christelle de la Fouchardière, Anne Ploquin, Anthony Turpin
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background BRAF V600E-mutant colorectal cancers (CRCs) are associated with shorter survival than BRAF wild-type tumors. Therapeutic decision-making for colorectal liver metastases (CRLM) harboring this mutation remains difficult due to the s
Externí odkaz:
https://doaj.org/article/396f97762c6d4546b3a537ee0d4435cb
Autor:
Philippe A. Cassier, Clémentine Peyramaure, Valery Attignon, Lauriane Eberst, Camille Pacaud, Sandrine Boyault, Françoise Desseigne, Mathieu Sarabi, Pierre Guibert, Pauline Rochefort, Nathalie Marques, Michel Rivoire, Aurélien Dupré, Patrice Peyrat, Catherine Terret, Isabelle Ray-Coquard, Clélia Coutzac, David Pérol, Jean-Yves Blay, Olivier Trédan, Christelle de la Fouchardière
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101266- (2022)
Background: Chemotherapy, anti-HER2 and PD-1 antibodies are standard treatments but only a minority of patients derive long-term benefit from these agents. Methods: In this report we describe the mutational landscape and outcome of patients with gast
Externí odkaz:
https://doaj.org/article/af51f8a698dc4ce7a25e81ac463e3700
Autor:
Maxime Lafond, Thomas Lambin, Robert Andrew Drainville, Aurélien Dupré, Mathieu Pioche, David Melodelima, Cyril Lafon
Publikováno v:
Cancers, Vol 14, Iss 11, p 2577 (2022)
Pancreatic ductal adenocarcinoma (PDAC) diagnosis accompanies a somber prognosis for the patient, with dismal survival odds: 5% at 5 years. Despite extensive research, PDAC is expected to become the second leading cause of mortality by cancer by 2030
Externí odkaz:
https://doaj.org/article/19e3ec31b416494c933b1234a4b7ca4c
Autor:
Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, Maxime Raddaz, Ellen Blanc, Olivier Msika, Isabelle Treilleux, Sophie Bachy, Anne Cattey-Javouhey, Pierre Guibert, Matthieu Sarabi, Pauline Rochefort, Pamela Funk-Debleds, Clélia Coutzac, Isabelle Ray-Coquard, Patrice Peyrat, Pierre Meeus, Michel Rivoire, Aurélien Dupré, Ana Hennino
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 4, p 623 (2022)
With an overall survival rate of 2–9% at 5 years, pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of cancer-related deaths in the industrialized world and is predicted to become the second by 2030. Owing to often late
Externí odkaz:
https://doaj.org/article/d308fe8081164885b112c72c96e6e3d1
Autor:
Mehdi Brahmi, Philippe Cassier, Armelle Dufresne, Sylvie Chabaud, Marie Karanian, Alexandra Meurgey, Amine Bouhamama, Francois Gouin, Gualter Vaz, Jerome Garret, Marie-Pierre Sunyach, Aurélien Dupré, Perrine Marec-Berard, Nadège Corradini, David Perol, Isabelle Ray-Coquard, Jean-Yves Blay
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233046 (2020)
RATIONALE:CSF1R tyrosine kinase inhibitors (TKI) and antibodies yield response rates and tumor control in patients with diffuse type tenosynovial giant cell tumors (dTGCT). The long term management of patients with dTGCT treated with TKI is however n
Externí odkaz:
https://doaj.org/article/23479515494d4d2b965f5f45c132fe2a
Publikováno v:
Cancers, Vol 13, Iss 24, p 6381 (2021)
Apart from palliative chemotherapy, no other therapy has been proven effective for the treatment of locally advanced pancreatic tumors. In this study, an intraoperative high-intensity focused ultrasound (HIFU) device was tested in vivo to demonstrate
Externí odkaz:
https://doaj.org/article/02800bde94404eb9a6c7f1af73f7b5ce
Autor:
Ophélie Aumont, Aurélien Dupré, Adeline Abjean, Bruno Pereira, Julie Veziant, Bertrand Le Roy, Denis Pezet, Emmanuel Buc, Johan Gagnière
Publikováno v:
BMC Surgery, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background Although drainage of pancreatic anastomoses after pancreaticoduodenectomy (PD) is still debated, it remains recommended, especially in patients with a high risk of post-operative pancreatic fistula (POPF). Modalities of drainage o
Externí odkaz:
https://doaj.org/article/53cad03f8d1e41aa951f110f489765a8